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ABSTRACT 
Objective: The major objective of the present study was to design, synthesize some Mannich base derivative of 2-substituted-5-amino thiadiazoles 
with primary amines/phthalimide and formaldehyde anticipating effective as antimicrobial agents.  
Methods: The efficient syntheses of substituted thiadiazole were done simply by reaction of substituted benzoic acid with thiosemicarbazide in 
presence of only conc. sulphuric acid. The isolated products were further subjected for Mannich reaction and evaluated for antibacterial activity.  
Results: Three substituted thiadiazoles (BA-1 to BA-3) were synthesized by solvent less efficient synthesis and their Mannich base derivates were 
also prepared with phthalimide, p-nitro/methyl/chloro-aniline. All characterized products were screened for antibacterial and antifungal activities. 
Among these compounds having nitro group (3,7,13) showed maximum activity followed by phthalimide, chloro and methyl groups.  
Conclusion: Thiadiazole-Mannich bases derivatives exhibited better antimicrobial activities then their starting components (BA-1 to BA-3) 
indicated joining different pharmacophore in the same molecule have increased activity.  
Keywords: Thiadiazole Mannich bases derivatives, Characterization, Antimicrobial activities. 
 
INTRODUCTION 
Heterocycles are widely used in the development of several 
pharmaceutically important compounds. The nitrogen and sulphur 
heterocyclic systems are very interesting because of their 
physicochemical properties with relevance to the design of new drugs. 
The compounds containing thiadiazole ring play a prominent role in 
natural processes and also found in numerous biologically active 
natural and synthetic compounds. According to the literature survey, 
thiadiazoles were reported to possess various pharmacological 
activities [1-7]. Anti-microbial activities of substituted thiadiazoles are 
well established because it posses (S–C=N) toxophoric unit. They have 
enhanced lipid solubility with hydrophilicity and can be easily 
metabolized by routine biochemical reactions. 
Mannich reaction is one of the versatile and convenient approaches to 
powerful C-C bond formation. It has wide application in organic 
synthesis and many drug molecules. However, the classical Mannich 
reaction has some limitations and to overcome these limitations, 
modern variants of this reaction came into the form of various 
publications [8-9]. Several medicinally useful Mannich base has been 
reviewed by various scientist [10-12]. Fascinated by various 
bioactivity of above mentioned compounds along with structure-based 
pharmacophore approaches in drug discovery and design, we have 
planned to design and synthesize thiadiazole-Mannich base analogues 
by using substituted aminothiadiazole, phthalimide, p-nitro/ 
methyl/chloro-aniline in presence of formaldehyde with a hope to 
develop new, potent, less toxic antimicrobial agents. In continuation of 
our research we studied the antimicrobial action of the resultant 
molecules against gram negative bacteria Escherichia coli, 
Pseudomonas aeruginosa and gram positive bacteria Staphylococcus 
aureus, Bacillus subtilis and along with a fungus Candida albicans. 
MATERIALS AND METHODS 
Chemicals and instrumentation 
Reagents such as thiosemicarbazide, phenyl propiolic acid/o-hydroxy 
benzoic/cinnamic acid, phthalimide, p-nitro aniline, p-methyl aniline, 
p-chloro aniline and formaldehyde were purchased from Across Ltd 
and used as it is. All the solvents were of analytical grade and were 
distilled before use. Melting points are uncorrected. The solid IR 
spectra were recorded in KBr on Perkin Elmer FTIR 
spectrophotometer at GITAM University, Visakhapatnam; however 1H 
and 13C NMR spectra were taken on Bruker 400 MHz NMR at Biocon 
Limited electronic city Bangalore, in DMSO-d6 using TMS as internal 
reference. Elemental analysis and mass spectra were recorded at 
Micro Analytical centre at Andhra University, Visakhapatnam. 
Synthesis of 2-amino-5-sustituted thiadiazole (BA-1 to BA-3) 
Substituted amino thiadiazoles were prepared by the conventional 
method as outlined in Scheme 1. A mixture of carboxylic acid (phenyl 
propiolic/o-OH-benzoic/cinnamic acid, 0.01 moles, in separate 
reactions) and thiosemicarbazide (0.012 mole) was mixed thoroughly. 
The reaction mixture was heated under reflux (Scheme 1) in the 
presence of only conc. H2SO4 without any solvent for 6-8 h [13]. The 
reaction mixture was cooled to room temperature and neutralized 
with ammonia solution. The solid were filtered and washed with water 
followed by few drops of ether. The products were re-crystallized from 
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Synthesis of BA1a/1b/1c to BA-3a/3b/3c 
A methanolic solution of BA-1/BA-2/BA-3 (0.01 mol) was taken (in 
separate reaction) in a round bottom flask equipped with a stirred 
and dropping funnel. The solution was stirred to dissolve it 
completely. To this methanolic solution of formaldehyde (3.0 ml) 
was added drop wise during 15-20 min. The resulting mixture was 
stirred during half an hour to complete the reaction. To this reaction 
mixture the methanolic solution of phthalimide/p-NO2/p-CH3/p-Cl 
aniline (0.01 mol) was added drop wise with stirring in about half an 
hour at 30 °C temperature and refluxed for 2 h at 65-75 °C (Scheme-
2). It was allowed to cool and poured in cold water. The solid 
obtained was filtered off washed thoroughly with hot water and air 
dried. All products were characterized by IR, NMR and were found 
consistent with an expected structure as shown in table 1. 
 
Scheme 2 
2-[5-amino-1,3,4-thiadiazol-2-yl] phenyl acetylene (BA-1) 
(C10H7N3S): IR(Vmax cm-1): 3465,3369 (NH2), 3104(Ar-H), 2106(
C C ),1627, 1519 (C=N); 1HNMR (δppm): 7.5-7.9 (Ar-H), 3.5(NH2), 
13CNMR(δppm): 86, 77 ( C C ), 126, 128,129, 130 (Ar-C), 157.7, 
152.5 (thiazole carbons); m/e: 201; Analysis: Calcd C, 59.70; H, 3.48; 
N, 20.89; Found: C, 59.75; H, 3.520; N, 20.83. 
2-({[5-phenyl acetylene)-1,3,4-thiadiazol-2-yl] amino} methyl)-
1-H-isoindole-1,3 (2H)-dione (BA-1a) 
(C19H12N4O2S): IR(γmax cm-1): 3460 (NH), 3100 (Ar-H), 2102 ( C C
), 1625, 1517 (C=N); 1HNMR (δppm): 7.4-7.8 (Ar-H), 3.8 (NH), 
13CNMR(δppm): 85, 76( C C ), 126.5, 128.8,129.7, 130.6 (Ar-C), 
157.5, 152.3 (thiazole carbons); m/e: 360; Analysis: Calcd C, 63.33; 
H, 3.33; N, 15.55; Found: C, 63.29; H, 3.38; N, 15.51. 
2-[5-({[(4-nitro phenyl)amino]methyl}amino)-1,3,4-thiazol-2-
yl] Phenyl acetylene (BA-1b) 
(C17H13N5O2S), IR(γ max cm-1): 3455, 3365 (NH), 3108 (Ar-H), 2100 (
C C ), 1623, 1515 (C=N); 1HNMR (δppm): 7.46-7.84 (Ar-H), 3.8.5 
(NH), 13CNMR (δppm): 84, 75 ( C C ), 126.3, 128.6,129.5, 130.4 
(Ar-C), 157.3, 152.1 (thiazole carbons); m/e: 351; Analysis: Calcd C, 
58.11; H, 3.70; N, 19.94; Found: C, 58.15; H, 3.66; N, 19.97. 
2-[5-({[(4-methyl phenyl) amino] methyl} amino)-1,3,4-thiazol-
2-yl ] Phenyl acetylene (BA-1c) 
(C17H16N4S) IR(γ max cm-1): 3450 (NH), 3105 (Ar-H), 2095 ( C C ), 
1621, 1513 (C=N); 1HNMR (δppm): 7.4.2-7.8.2 (Ar-H), 3.9 (NH), 
13CNMR(δppm): 84.5, 75.5 ( C C), 126.1, 128.3,129.3, 130.2 (Ar-C), 
157, 152 (thiazole carbons); m/e: 308; Analysis: Calcd C, 66.23; H, 
5.19; N, 18.18; Found: C, 66.29; H, 5.14; N, 18.14. 
2-[5-({[(4-choloro amino] methyl} amino)-1,3,4-thiazol-2-yl] 
Phenol (BA-1d) 
(C17H15N4SCl): IR(γ max cm-1): 3445 (NH), 3105 (Ar-H), 2095 ( C C
), 1621, 1513 (C=N); 1HNMR (δppm): 7.4.2-7.8.2 (Ar-H), 3.95 (NH), 
13CNMR(δppm): 84., 75 ( C C ), 125, 127, 128, 131 (Ar-C), 157, 152 
(thiazole carbons); m/e: 342.5; Analysis: Calcd C, 59.56; H, 4.37; N, 
16.35; Found: C, 59.61; H, 4.33; N, 16.39. 
2-(5-amino-1,3,4-thiadiazol-2-yl) phenol (BA-2) 
(C8H7N3OS): IR(γ max cm-1): 3469 (OH), 3206 (NH2), 3006 (Ar-H), 
1627, 1519 (C=N); 1HNMR(δ ppm): 9.9 (O-H); 6.6.7-7.4 (Ar-H), 
3.5(NH2); 13CNMR(δppm): 116, 118, 130,134 (Ar-C), 158, 152 
(thiazole carbons); m/e: 193; Analysis: Calcd C, 49.74; H, 3.62; N, 
21.76; Found: C, 49.68; H, 3.59; N, 21.72. 
2-({[5-2-hydroxy phenyl)-1,3,4-thiadiazol-2-yl] amino}methyl)-
1-H-isoindole-1,3(2H)-dione (BA-2a) 
(C17H12N4O3S): IR(γ max cm-1): 3465 (OH), 3335, NH), 3004 (Ar-H), 
1625, 1517 (C=N); 1HNMR(δ ppm): 9.8(O-H); 6. 8-7.5 (Ar-H), 3.8 
(NH); 13CNMR (δppm): 115, 117, 129,133 (Ar-C), 157, 151 (thiazole 
carbons); m/e: 352; Analysis: Calcd C, 57.95; H, 3.40; N, 19.94; 
Found: C, 57.92; H, 3.43; N, 15.95. 
2-[5-({[(4-nitro phenyl) amino] methyl} amino)-1,3,4-thiazol-2-
yl] Phenol (BA-2b) 
(C15H13N5O3S): IR(γ max cm-1): 3463(OH), 3333 (NH), 3002 (Ar-H), 
1624.5, 1516.7 (C=N); 1HNMR(δppm): 9.76 (O-H); 6.6.6-7.3.7 (Ar-H), 
3.9 (NH); 13CNMR (δppm): 115.4, 118.6, 128.5,132.7 (Ar-C), 156, 
151.6 (thiazole carbons); m/e: 343; Analysis: Calcd C, 52.47; H, 3.79; 
N, 20.40; Found: C, 52.52; H, 3.75; N, 20.36. 
2-[5-({[(4-methyl phenyl) amino] methyl} amino)-1,3,4-thiazol-
2-yl] Phenol (BA-2c) 
(C16H16N4OS): IR(γ max cm-1): 3462(OH), 3330 (NH), 3001 (Ar-H), 
1624, 1515.6 (C=N); 1HNMR(δppm): 9.74 (O-H); 6.6-7.3 (Ar-H), 3.94 
(NH); 13CNMR (δppm): 115, 118, 128,132 (Ar-C), 155, 151 (thiazole 
carbons); m/e: 312; Analysis: Calcd C, 61.53; H, 5.12; N, 17.94; 
Found: C, 61.49; H, 5.16; N, 17.95. 
2-[5-({[(4-choloro phenyl) amino] methyl} amino)-1,3,4-
thiazol-2-yl] Phenol (BA-2d) 
(C15H13N4OSCl): IR(γ max cm-1): 3460(OH), 3328 (NH), 3000 (Ar-H), 
1623, 1515 (C=N); 1HNMR(δppm): 9.72 (O-H); 6.8-7.6 (Ar-H), 3.92 
(NH); 13CNMR (δppm): 114, 117, 127,131 (Ar-C), 154.8, 150.7 
(thiazole carbons); m/e: 332.5; Analysis: Calcd C, 54.13; H, 3.90; N, 
16.84; Found: C, 54.17; H, 3.86; N, 16.81. 
2-(5-amino-1,3,4-thiadiazol-2-yl) phenyl ethylene (BA-3) 
(C10H9N3S): IR(γ max cm-1): 3360 (NH2), 3104 (Ar-H), 1673 (HC=CH), 
1519, 1459 (C=N); 1HNMR (δ ppm):7.2-7.5 (AR-H), 4.8-5.3 (=C-H), 
3.5 (NH2); 13CNMR (δppm): 118, 126, 128, 130 (Ar-C), 154 (C=C), 
152, 159 (thiazole carbons); m/e: 203; Analysis: Calcd C, 59.11; H, 
4.43; N, 20.68; Found: C, 59.15; H, 4.48; N, 20.73. 
2-({[5-phenyl ethylene)-1,3,4-thiadiazol-2-yl] amino}methyl)-1-
H-isoindole-1,3(2H)-dione (BA-3a) 
(C19H14N4O2S): IR(γ max cm-1): 3358 (NH), 3103 (Ar-H), 1672 
(HC=CH), 1518, 1458 (C=N); 1HNMR (δppm):7.1-7.6 (AR-H), 4.8-5.5 
(=C-H), 3.7 (NH);13CNMR (δppm): 117, 125, 127, 129 (Ar-C), 153 
(C=C), 151, 158 (thiazole carbons); m/e: 362; Analysis: Calcd C, 
62.98; H, 3.86; N, 11.60; Found: C, 62.95; H, 3.91; N, 11.56. 
2-[5-({[(4-nitro phenyl) amino] methyl}amino)-1,3,4-
thiadiazol-2-yl] phenyl ethylene (BA-3b) 
(C17H15N5O2S), IR(γ max cm-1): 3355 (NH), 3102 (Ar-H), 1671 
(HC=CH), 1517, 1457 (C=N); 1HNMR (δppm):7.0-7.7 (AR-H), 4.7-5.6 
(=C-H), 3.8 (NH);13CNMR (δppm): 116, 124, 126, 128 (Ar-C), 152 
(C=C), 150.8, 157.6 (thiazole carbons); m/e: 353; Analysis: Calcd C, 
57.79; H, 4.24; N, 19.83; Found: C, 57.75; H, 4.28.; N, 19.86. 
2-[5-({[(4-methyl phenyl) amino] methyl}amino)-1,3,4-
thiadiazol-2-yl] phenyl ethylene (BA-3c) 
(C18H18N4S): IR(γ max cm-1): 3353 (NH), 3100 (Ar-H), 1670 (HC=CH), 
1516, 1456 (C=N); 1HNMR (δppm):6.9-7.8 (AR-H), 4.7-5.7 (=C-H), 
3.9 (NH);13CNMR (δppm): 115, 123, 125.6, 127.4 (Ar-C), 151 (C=C), 
149, 157.36 (thiazole carbons); m/e: 322; Analysis: Calcd C,67.08; H, 
5.59; N,17.39; Found: C, 63.51; H, 4.12; N, 21.85. 
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2-[5-({[(4-choloro phenyl) amino] methyl} amino)-1,3,4-
thiadiazol-2-yl] phenyl ethylene (BA-3d) 
(C17H15N4SCl): IR(γ max cm-1): 3350(NH), 3090 (Ar-H), 1669 
(HC=CH), 1515, 1455 (C=N); 1HNMR (δppm):7.0-7.9 (AR-H), 4.8-5.8 
(=C-H), 3.9.5 (NH);13CNMR (δppm): 114.7, 122.6, 125, 127 (Ar-C), 
150 (C=C), 147, 157 (thiazole carbons); m/e: 342.5; Analysis: Calcd 
C, 59.56; H, 4.37; N, 16.35; Found: C, 59.59; H, 4.34; N, 16.38. 
Antimicrobial assay  
The synthesized compounds (1–15) were assessed for 
antimicrobial assay against gram positive bacteria BS-Bacillus 
subtilis (MTCC 441), SA-Staphylococcus aureus (MTCC 96), and 
gram negative bacteria EC-Escherichia coli (MTCC 1687), PA-
Pseudomonas aeruginosa (MTCC 424) along with a fungal strain 
CA-Candida albicans using the well diffusion method[14]. The 
compounds were dissolved in DMSO and activity was 
determined using serial dilution method. The whole procedure 
was carried out as reported by us earlier [15]. Ciprofloxacin and 
ketaconazole were used as antibacterial and antifungal reference 
drugs, respectively. The minimum inhibitory concentration (MIC, 
10 μg ml-1) was determined for each compound in triplicate 
experiments; the values were averaged and are presented in 
table 2. 
 
Table 1: Structure and physical properties of synthesized compounds 
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 Table 2: The MIC* values of the synthesized compounds for antibacterial and antifungal activity at 10 µg/ml concentration 
  Bacteria Fungus 
S. No. Compound EC PA BS SA CA 
1 BA-1 12 10 10 9 7 
2 BA-1a 17 17 10 11 16 
3 BA-1b 21 15 NA 13 10 
4 BA-1c 12 10 17 15 22 
5 BA-1d 14 16 12 NA 15 
6 BA-2 10 6 9 13 11 
7 BA-2a 13 9 15 9 9 
8 BA-2b 16 12 10 15 17 
9 BA-2c 12 8 NA 12 19 
10 BA-2d 9 11 12 14 NA 
11 BA-3 12 NA 9 8 12 
12 BA-3a 15 12 12 NA NA 
13 BA-3b 19 7 10 12 10 
14 BA-3 c 12 9 11 7 17 
15 BA-3d 10 8 14 9 14 
16 Cephaloflaxin 25 18 20 19 - 
17 Ketoconazole - - - - 26 
* MIC =minimum inhibitory concentration (Mean of triplicate experiments)  
NA-Not active, EC-Escherichia coli, PA-Pseudomonas aeruginosa, BS-Bacillus subtilis, SA-Staphylococcus aureus, CA-Candida albicans 
 
RESULTS AND DISCUSSION 
Synthesis of 1, 3, 4-thiadiazole analogs  
Synthesis of novel 1, 3, 4-thiadiazole analogs were achieved by following 
the procedure as depicted in Scheme 1 and 2. The stoichiometric ratio of 
thiosemicarbazide and (phenyl propiolic/o-OH-benzoic/cinnamic acid 
was grinded thoroughly in the mortar and pestle. The reaction mixture 
was further refluxed [14] in the presence of only conc. H2SO4, which was 
used as cyclising agent. The isolated and characterized substituted thia 
diazoles (BA-1 to BA-3) were further condensed with phthalimide/p-
NO2/p-CH3/p-Cl aniline in the presence of formaldehyde to get Mannich 
base derivatives. TLC was run throughout the reaction to optimize the 
reaction for purity and completion.  
Designed series of molecules (1-15: BA-1 to BA-3, BA-1a/b/c/d to 
BA-3a/b/c/d) was characterized by spectral techniques before 
evaluating for antimicrobial studies. Two strong absorption bands 
appeared in the range between 3340 and 3200 cm-1 in the IR spectra 
of compounds (1,6,11) was attributed to NH2 group[16] of 
substituted thiadiazole, while C-S-C absorption stretches 
(thiadiazole ring)[17] from 1150 to 1180 cm-1 and C=N absorptions 
(thiadiazole ring) from 1604 to 1623 cm-1. The other major peaks 
observed in the IR of these compounds are 3130–3050; 1550-1520 
cm-1 could be assigned to aromatic hydrogen and C=C of the ring. 
The additional peak observed in the IR of 16: BA-3 at 1623 cm-1 was 
attributed to CH=CH of cinnamic acid. The disappearance of NH2 
peaks of substituted thia diazoles (compound no.1,6,11) in the IR of 
target compounds (2-5, 7-10 and 12-15) are clearly indicated the 
condensation of it with formaldehyde and various substituted 
aniline/phthalimide which was further confirmed by their NMR 
spectra. The additional peak observed at the range of 1770-1735 cm-
1 in compound no.2,7,12 was attributed to C=O of phthalimide 
ring[18]. Other peaks observed in the IR spectrum of all the 
compounds were fitted well as expected structure shown in table 1. 
The major proton NMR spectral peaks appeared at δ 3.2-3.9 and 6.7-
7.8 ppm in the compounds (1, 6, 11) was assigned to NH2 and 
aromatic. In the 13C NMR spectra, the signals in the range δ 110-135 
ppm are due to aromatic carbons and signals in the region δ 150-170 
ppm are due to thia diazole carbons[19]. The disappearance of NH2 
and carbonyl peak in the 1H NMR spectra of compounds (2-5,7-10,12-
15) were further supportive of condensation of amino thia diazoles 
with formaldehyde and various substituted aniline/phthalimide. The 
additional peaks at δ 4.2-4.5 ppm were assigned to CH2 of Mannich 
base derivatives [20]. The observed signals in 13C NMR spectra of 
compounds (2-5,7-10 and 12-15) in the range of δ 33.41-38.55 ppm 
are due the formation of-N-CH2-N-of derivatives [21] of thiadiazole. 
Other proton and carbon peaks were found to be well consistent with 
the expected structures. All the compounds showed a single peak in 
their mass spectra suggesting their purity.  
All synthesized and characterized compounds (1–15) were 
evaluated for their antibacterial activity against gram positive 
bacteria-Bacillus subtilis, Staphylococcus aureus and gram negative 
bacteria Escherichia coli, Pseudomonas aeruginosa together with a 
fungus Candida albicans using well diffusion method,and compared 
with well-known antibacterial/antifungal drug, Ciprofloxacin/ 
ketaconazole. The minimum inhibitory concentration (MIC, 10μg ml-
1) was determined for each compound in triplicate experiments. The 
values were averaged and reported in table 2 while graphically 
shown in fig. 1. 
The observed values reveal that type of substituent directly attached 
to 1, 3, 4-thiadiazole ring has a significant impact on the 
antibacterial/antifungal activities of these novel analogs. In 
particular, compound no.3, 7, 13 showed the activity to a greater 
extent due to the presence of nitro group [22]. However, the chloro 
[23] containing compounds 5, 10, and 15 showed significant activity 
against all five microorganisms. In light of the various available 
literature describing biological activities of compounds containing 
phthalimides, we also noticed the compounds 2,7,12 showed 
appreciable activity. Additionally, unsaturation [24] plays some role 
in activity since compounds having triple bond (1-5) showed better 
activity then compound having the double bond (11-15). However, 
the trend observed in all synthesized compounds containing nitro, 
chloro and methyl is in decreasing order (BA-1, BA-2, BA-3) and well 
consistent with literature.  
 
 
Fig. 1: Graphical representation of antimicrobial activity of 
synthesized compounds (1-15) 
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The present work provides a convenient and efficient route for the 
preparation of new substituted thiadiazole (BA-1, BA-2, BA-3) and 
their Mannich base derivatives. All the newly synthesized 
compounds have been screened for their antimicrobial activities. 
Most of the tested compounds exhibited activities against the strains 
used. Our present results demonstrated that the presence of nitro 
group has the significant effect on activity, which was followed by 
chloro, methyl groups. However, phthalimide had showed 
appreciable activity in all three cases.  
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